Table of Contents
Hepatitis Research and Treatment
Volume 2011, Article ID 972759, 6 pages
http://dx.doi.org/10.1155/2011/972759
Clinical Study

Validation of Hepascore as a Predictor of Liver Fibrosis in Patients with Chronic Hepatitis C Infection

1Department of Gastroenterology, Liver Diseases Research Center, Isfahan University of Medical Sciences, 81876-98191 Isfahan, Iran
2Department of Gastroenterology, School of Medicine, Isfahan University of Medical Sciences, 81876-98191 Isfahan, Iran
3Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, 81876-98191 Isfahan, Iran

Received 18 September 2011; Accepted 17 November 2011

Academic Editor: Fabio Grizzi

Copyright © 2011 Hamid Kalantari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Becker, W. Salameh, A. Sferruzza et al., “Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States,” Clinical Gastroenterology and Hepatology, vol. 7, no. 6, pp. 696–701, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. D. B. Strader, T. Wright, D. L. Thomas, and L. B. Seeff, “Diagnosis, management, and treatment of hepatitis C,” Hepatology, vol. 39, no. 4, pp. 1147–1171, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. “EASL international consensus conference on hepatitis C, Paris, 26–27 February 1999: consensus statement,” Journal of Hepatology, vol. 31, supplement 1, pp. 3–8, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Bedossa, D. Dargère, and V. Paradis, “Sampling variability of liver fibrosis in chronic hepatitis C,” Hepatology, vol. 38, no. 6, pp. 1449–1457, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. A. Bravo, S. G. Sheth, and S. Chopra, “Liver biopsy,” The New England Journal of Medicine, vol. 344, no. 7, pp. 495–500, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. F. Cadranel, P. Rufat, and F. Degos, “Practices of liver biopsy in France: results of a prospective nationwide survey,” Hepatology, vol. 32, no. 3, pp. 477–481, 2000. View at Google Scholar
  7. I. Gilmore, A. Burroughs, and I. Murray, “Indications, methods, and out comes of percutaneuos liver biopsy in England and Wales: an audit by the British Society of Gastroentrology and the royal college of physicians of London,” Gut, vol. 36, pp. 473–441, 2002. View at Google Scholar
  8. A. Regev, M. Berho, L. J. Jeffers et al., “Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection,” American Journal of Gastroenterology, vol. 97, no. 10, pp. 2614–2618, 2002. View at Publisher · View at Google Scholar
  9. M. C. Rousselet, S. Michalak, F. Dupré et al., “Sources of variability in histological scoring of chronic viral hepatitis,” Hepatology, vol. 41, no. 2, pp. 257–264, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. C. Lackner, G. Struber, B. Liegl et al., “Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C,” Hepatology, vol. 41, no. 6, pp. 1376–1382, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. C. T. Wai, J. K. Greenson, R. J. Fontana et al., “A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C,” Hepatology, vol. 38, no. 2, pp. 518–526, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. L. A. Adams, M. Bulsara, E. Rossi et al., “Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection,” Clinical Chemistry, vol. 51, no. 10, pp. 1867–1873, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. Parkes, I. N. Guha, P. Roderick, and W. Rosenberg, “Performance of serum marker panels for liver fibrosis in chronic hepatitis C,” Journal of Hepatology, vol. 44, no. 3, pp. 462–474, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. J. Guéchot, E. Lasnier, N. Sturm, A. Paris, and J. P. Zarski, “Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort,” Clinica Chimica Acta, vol. 411, no. 1-2, pp. 86–91, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. H. Kalantari, F. Kazemi, and M. Minakari, “Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C,” Journal of Research in Medical Sciences, vol. 12, no. 4, pp. 178–185, 2007. View at Google Scholar · View at Scopus
  16. V. Leroy, M. N. Hilleret, N. Sturm et al., “Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C,” Journal of Hepatology, vol. 46, no. 5, pp. 775–782, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. P. Halfon, Y. Bacq, A. de Muret et al., “Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C,” Journal of Hepatology, vol. 46, no. 3, pp. 395–402, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus